This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mylan Appoints Jacek Glinka As President Of Mylan's European Business

PITTSBURGH, Oct. 17, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the appointment of Jacek Glinka as president of Mylan's European business, effective Dec. 2, 2013. Glinka will report to Hal Korman, Mylan's chief operating officer.

Prior to joining Mylan, Glinka served as chief executive officer for the Polpharma Group from 2003 to 2006 and from 2009 to 2013. During his tenure, Glinka led the transformation of Polpharma from a small local player into a leading pharmaceutical company in Central and Eastern Europe, the Caucasus and Central Asia. Under his leadership, Polpharma became the leader in the Polish market and one of the fastest growing pharmaceutical companies in the region. From 2011 to 2013, Polpharma doubled its revenue to more than $1 billion. Glinka also led Polpharma in the successful acquisition and integration of a number of businesses including Chimpharm in Kazakhstan; Polfa Warsaw in Poland; the antibiotics division of Bioton in Poland; and the nutraceuticals portfolio of Herbapol. Additionally, Glinka led the company's strategic expansion into new geographies, both organically and through acquisition, including Kazakhstan, Uzbekistan, Azerbaijan and Vietnam. He also enhanced the company's organizational structure and processes, and implemented several corporate-wide cost reduction programs resulting in substantial improvements in Polpharma's profitability.

Mylan CEO Heather Bresch commented, "We are thrilled to welcome Jacek to Mylan. His exceptional track record leading Polpharma speaks for itself and we believe his deep experience in the region will contribute to Mylan's continued success and growth in Europe. We believe Jacek's strong leadership, strategic thinking and operational discipline will build on the solid foundation and leadership team we already have in place, and maximize the many opportunities we see ahead for our European business."

Glinka said, "I have been following Mylan closely for some time and believe its massive global scale, vertical integration, broad product portfolio and unwavering commitment to quality are true differentiators in the highly competitive and diverse European market. I look forward to working with Mylan's global and regional leaders to continue to maximize the power of the Mylan platform across the region and further solidify Mylan's leadership positions in key markets. I also look forward to leveraging my expertise, particularly in the exciting Central and Eastern European markets, to further expand Mylan's footprint."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 0.21%
FB $116.73 0.00%
GOOG $691.02 0.00%
TSLA $248.99 0.52%
YHOO $36.76 0.46%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs